Richard Ian Griffiths - 10 Apr 2025 Form 4 Insider Report for Silence Therapeutics plc (SLN)

Role
10%+ Owner
Signature
/s/ Richard Ian Griffiths
Issuer symbol
SLN
Transactions as of
10 Apr 2025
Net transactions value
$0
Form type
4
Filing time
15 Apr 2025, 14:17:20 UTC
Previous filing
01 Apr 2025
Next filing
22 Apr 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SLN American Depositary Shares Purchase +25,193 +0.26% 9,886,492 10 Apr 2025 Ordinary Shares 75,579 $2.14 Direct F1
transaction SLN American Depositary Shares Purchase +56,480 +0.57% 9,942,972 11 Apr 2025 Ordinary Shares 169,440 $2.33 Direct F1
transaction SLN American Depositary Shares Purchase +40,409 +0.41% 9,983,381 14 Apr 2025 Ordinary Shares 121,227 $2.71 Direct F1
transaction SLN American Depositary Shares Purchase +50,000 +0.5% 10,033,381 14 Apr 2025 Ordinary Shares 150,000 $2.65 Direct F1
transaction SLN American Depositary Shares Purchase +27,918 +0.28% 10,061,299 15 Apr 2025 Ordinary Shares 83,754 $2.78 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each American Depositary Share ("ADS") is immediately convertible into three ordinary shares for no consideration and has no expiration date.